Community Health Systems Announces \$110 Million Sale of Arkansas Facilities
Key Transaction Details
Community Health Systems, Inc. (CHS) has completed the sale of four Arkansas hospitals and associated outpatient centers and practices to Freeman-Oak Hill Health System (Freeman Health), as outlined in an asset purchase agreement signed earlier in the year. The facilities sold include:
- Northwest Medical Center – Bentonville (Bentonville, AR)
- Northwest Medical Center – Springdale (Springdale, AR)
- Northwest Medical Center – Willow Creek Women’s Hospital (Johnson, AR)
- Siloam Springs Regional Hospital (Siloam Springs, AR)
The sale was completed on June 1, 2026. The purchase price paid to CHS at closing was \$110 million in cash, subject to a post-closing working capital adjustment. The Purchaser also assumed certain finance leases related to these facilities.
Financial Highlights and Impact
- Pro Forma Adjustments: The unaudited pro forma condensed consolidated financial statements reflect the transaction as if it had occurred as of March 31, 2026, and include adjustments to illustrate its impact for the three months ended March 31, 2026 and the year ended December 31, 2025.
- Estimated Loss on Sale: The company recorded a pre-tax loss of \$55 million (after-tax loss of \$48 million) in connection with the sale. This loss is reflected in the accumulated deficit within the balance sheet.
-
Balance Sheet Impact:
- Cash and cash equivalents increased by \$107 million, reflecting the net proceeds from the transaction.
- Total assets decreased from \$13,180 million (as reported) to \$13,065 million (pro forma), mainly due to the elimination of assets related to the divested facilities.
- Total liabilities decreased by \$67 million, primarily from the removal of liabilities associated with the sold facilities.
- Stockholders’ deficit increased by \$48 million, mainly due to the loss on sale.
-
Income Statement Impact:
- For Q1 2026, pro forma net operating revenues decreased by \$111 million, with corresponding reductions in operating costs and expenses.
- For full year 2025, pro forma net operating revenues decreased by \$415 million, with operating costs and expenses reduced by \$367 million.
- Net income attributable to CHS stockholders for 2025 decreased from \$509 million as reported to \$472 million pro forma, a drop of \$37 million, factoring in the loss on sale and adjustments.
- Earnings per share for 2025 declined from \$3.81 (basic) to \$3.53 (pro forma basic), and from \$3.77 (diluted) to \$3.50 (pro forma diluted).
- Tax Effects: For the year ended December 31, 2025, there was an income tax benefit of \$2 million related to the elimination of revenues, costs, and expenses, plus a \$7 million benefit related to the sale loss.
- Discontinued Operations: The divested operations do not meet the criteria for discontinued operations under ASC 205, meaning future CHS financial statements will not present these as discontinued.
What Investors Should Know
- Material Transaction: The sale of the Arkansas facilities is a significant event for CHS, as it impacts the scale, revenues, and earnings of the company. The reduction in assets and revenues, as well as the recorded loss, could be material for investors.
- Impact on Shareholder Value: The recorded loss on sale (\$48 million after-tax) and the decrease in earnings per share are potentially price sensitive. Investors should consider how the reduction in operational footprint and the one-time loss may affect future valuation and share price.
- Cash Position: The transaction has strengthened the company’s cash position by \$107 million, which could support debt repayment, strategic investments, or shareholder returns, but also reflects a strategic shift in the company’s portfolio.
- Future Outlook: Pro forma financial information should not be used to predict future performance, as it does not include management’s intended actions post-transaction, nor does it reflect possible changes in operating practices or strategy.
Additional Details
- The pro forma statements were prepared in accordance with Article 11 of Regulation S-X and do not include all disclosures required by GAAP. They are intended to illustrate the objectively measurable effects of the sale transaction based on historical amounts.
- Adjustments include the elimination of assets and liabilities related to the sold facilities, the addition of sale proceeds net of expenses, and the allocation of goodwill to the facilities sold.
- The company’s continuing operations exclude the facilities sold, and pro forma adjustments do not include certain general corporate overhead costs that will persist post-sale.
Conclusion
The sale of the four Arkansas hospitals and related outpatient centers is a major transaction for Community Health Systems, Inc. The direct financial impacts—including the reported loss, decrease in revenues and earnings, and strengthened cash position—are material and may influence the company’s share price. Investors should monitor subsequent filings and management commentary for further strategic developments.
Disclaimer
This article is based on unaudited pro forma financial statements and company disclosures. It does not constitute investment advice. Investors should perform their own due diligence and consult professional advisors before making any investment decisions. Actual future financial performance may differ materially from pro forma illustrations.
